In the last week, the Pharma industry is up 1.8%, with GSK up 4.0%. Meanwhile, Alliance Pharma actually underperformed within the industry, shrinking 14% in the last week. In the last 12 months, the industry was up 6.6%. Earnings are forecast to grow by 15% annually.
Has the U.K. Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Thu, 09 May 2024 | UK£270.4b | UK£72.2b | UK£9.6b | 33.1x | 28x | 3.7x |
Sat, 06 Apr 2024 | UK£240.7b | UK£70.8b | UK£9.7b | 31.4x | 24.8x | 3.4x |
Mon, 04 Mar 2024 | UK£233.3b | UK£70.7b | UK£9.7b | 30.9x | 23.9x | 3.3x |
Wed, 31 Jan 2024 | UK£237.9b | UK£68.9b | UK£10.7b | 36.1x | 22.3x | 3.5x |
Fri, 29 Dec 2023 | UK£234.9b | UK£68.8b | UK£10.7b | 35.4x | 22x | 3.4x |
Sun, 26 Nov 2023 | UK£227.1b | UK£69.2b | UK£10.7b | 53x | 21.2x | 3.3x |
Tue, 24 Oct 2023 | UK£229.7b | UK£70.4b | UK£10.3b | 53.8x | 22.3x | 3.3x |
Thu, 21 Sep 2023 | UK£246.6b | UK£70.0b | UK£10.3b | 55.1x | 24x | 3.5x |
Sat, 19 Aug 2023 | UK£234.0b | UK£68.9b | UK£10.2b | 53.5x | 23x | 3.4x |
Mon, 17 Jul 2023 | UK£226.8b | UK£66.7b | UK£7.8b | 54.3x | 29.2x | 3.4x |
Wed, 14 Jun 2023 | UK£250.8b | UK£68.1b | UK£7.9b | 54.6x | 31.7x | 3.7x |
Fri, 12 May 2023 | UK£257.0b | UK£68.4b | UK£8.0b | 58.1x | 32.3x | 3.8x |
Sun, 09 Apr 2023 | UK£254.7b | UK£69.3b | UK£6.9b | 50.5x | 37.1x | 3.7x |
Tue, 07 Mar 2023 | UK£237.3b | UK£70.5b | UK£7.0b | 50.3x | 34.1x | 3.4x |
Thu, 02 Feb 2023 | UK£230.3b | UK£79.3b | UK£6.3b | 38.2x | 36.5x | 2.9x |
Sat, 31 Dec 2022 | UK£244.5b | UK£80.2b | UK£6.3b | 37.3x | 38.5x | 3x |
Mon, 28 Nov 2022 | UK£237.5b | UK£80.1b | UK£6.3b | 33.2x | 37.5x | 3x |
Wed, 26 Oct 2022 | UK£217.4b | UK£80.0b | UK£3.7b | 22.2x | 59.1x | 2.7x |
Fri, 23 Sep 2022 | UK£216.8b | UK£80.8b | UK£3.7b | 14.3x | 59x | 2.7x |
Sun, 21 Aug 2022 | UK£244.7b | UK£78.8b | UK£3.7b | 14.8x | 65.5x | 3.1x |
Tue, 19 Jul 2022 | UK£272.4b | UK£75.6b | UK£4.6b | 16.1x | 59.6x | 3.6x |
Thu, 16 Jun 2022 | UK£251.7b | UK£75.0b | UK£4.6b | 15.8x | 55.2x | 3.4x |
Sat, 14 May 2022 | UK£260.9b | UK£74.5b | UK£4.6b | 16.3x | 57.1x | 3.5x |
Mon, 11 Apr 2022 | UK£275.1b | UK£66.8b | UK£4.8b | 20.5x | 57.2x | 4.1x |
Wed, 09 Mar 2022 | UK£226.4b | UK£66.7b | UK£4.7b | 24.2x | 47.7x | 3.4x |
Fri, 04 Feb 2022 | UK£227.4b | UK£61.2b | UK£5.6b | 31.5x | 40.4x | 3.7x |
Sun, 02 Jan 2022 | UK£234.6b | UK£61.3b | UK£5.6b | 32.5x | 41.7x | 3.8x |
Tue, 30 Nov 2021 | UK£225.3b | UK£61.8b | UK£5.7b | 29.7x | 39.8x | 3.6x |
Thu, 28 Oct 2021 | UK£231.9b | UK£58.3b | UK£7.5b | 26.4x | 31x | 4x |
Sat, 25 Sep 2021 | UK£227.7b | UK£58.4b | UK£7.5b | 29.3x | 30.2x | 3.9x |
Mon, 23 Aug 2021 | UK£230.4b | UK£58.1b | UK£7.5b | 28.3x | 30.7x | 4x |
Sat, 10 Jul 2021 | UK£204.4b | UK£58.1b | UK£7.5b | 26.5x | 27.2x | 3.5x |
22.4x
Which industries have driven the changes within the U.K. Healthcare industry?
GB Market | 2.66% | |
Healthcare | 1.91% | |
Pharma | 1.68% | |
Pharma | 1.68% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
GSK GSK | UK£17.74 | 4.0% +UK£2.8b | 23.5% | PE16.1x | |
AZN AstraZeneca | UK£122.64 | 0.8% +UK£1.5b | 3.8% | PE37.5x | |
HCM HUTCHMED (China) | UK£3.13 | 4.3% +UK£111.0m | 38.5% | PE33.1x | |
HIK Hikma Pharmaceuticals | UK£19.73 | 2.0% +UK£84.3m | 6.1% | PE28.8x | |
FUM Futura Medical | UK£0.41 | 23.7% +UK£23.5m | -14.4% | PS39.6x |